Global Defibrillators Market to Surpass US$ 26,235.6 Million by 2030 - Coherent Market Insights

SEATTLE, Aug. 16, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global defibrillators market is estimated to be valued at US$ 16,83.5 million in 2022 and is expected to exhibit a CAGR of 5.7% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Defibrillators Market:

Key players in market are focused on expanding their product portfolio through new product approvals. For instance, in April 2019, Stryker launched new defibrillation solution LIFEPAK CR2 defibrillator with LIFELINK central automated external defibrillator program manager for analysis of heart rhythm during Cardiopulmonary resuscitation, in the U.S. Furthermore, increasing merger and acquisition activities are also expected to drive growth of the global defibrillators market during the forecast period. For instance, in January 2017, Abbott, Medical Device Company announced acquisition of St. Jude Medical, Inc., medical device company. The acquisition helped Abbott to strengthen its market positioning and increase product offering in the defibrillators market.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/115

Key Market Takeaways:

Global defibrillators market is expected to exhibit a CAGR of 5.7% during the forecast period due to the increasing adoption of inorganic strategies such as merger and acquisition by key players in market. For instance, in February 2022, Boston Scientific Corporation, a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices, acquiesced, Baylis Medical Company Inc., medical devices company. This acquisition allows Boston Scientific to integrate the Baylis platforms with our existing electrophysiology and structural heart offerings, further strengthening our position within the highest growth cardiology markets. The transaction consists of an upfront payment of $1.75 billion, and is expected to be approximately one cent accretive to adjusted earnings per share in 2022 and increasingly accretive thereafter.

Among product type, the implantable cardioverter defibrillators (ICD) segment accounted for the major market share in the global defibrillators market in 2022, owing to increasing product approvals and clinical research of defibrillators in major developed and emerging economies. For instance, in May 2019, BIOTRONIK, cardiovascular biomedical research and Technology Company, started next-gen trial to study the clinical safety and workflow benefits of implantable cardioverter-defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) systems.

Key players operating in the global defibrillators market include Koninklijke Philips N.V., Metrax GmbH, Medtronic, Mindray Medical International Limited, Boston Scientific Corporation, GE Healthcare, Nihon Kohden, Abbott, BIOTRONIK, Stryker, and LivaNova PLC.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/115

Detailed Segmentation:

Global Defibrillators Markets, By Product Type:

• Implantable Cardioverter Defibrillators
• Single Chamber Implantable Cardioverter Defibrillators
• Dual Chamber Implantable Cardioverter Defibrillators
• External Defibrillators
• Manual External Defibrillators
• Automated External Defibrillators
• Wearable Cardioverter Defibrillators

Global Defibrillators Markets, By End User:

• Hospitals
• Cardiac Clinics
• Ambulatory Surgical Centers

Global Defibrillators Markets, By Region:

• North America
• By Country:
• U.S.
• Canada
• Europe
• By Country:
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country:
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• By Country:
• GCC Countries
• Israel
• South Africa
• Rest of Middle East & Africa

Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/115

Find related trending report below:

Implantable Cardioverter-defibrillators Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com 
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg